Drug
vimseltinib
Marketed as ROMVIMZA.
Generic name
vimseltinib
Brand names
ROMVIMZA
First FDA approval
2025-02-14
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA219304 | ROMVIMZA | 2025-02-14 | DECIPHERA PHARMS |
Manufacturers
DECIPHERA PHARMS
Frequently asked questions
When was vimseltinib FDA approved?
Earliest FDA approval on record: 2025-02-14.
What brand names are sold as vimseltinib?
ROMVIMZA.
Sources
Appeal a vimseltinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com